Disclosed is the discovery that the transcription elongation factor termed P-TEFb has a central role in transcription elongation control. P-TEFb is herein shown to phosphorylate RNA polymerase II and to control the transition from abortive into productive elongation mode. P-TEFb has also been discovered to interact with the HIV transcriptional transactivating protein, Tat, showing that P-TEFb is the cellular factor necessary for HIV Tat to effect productive viral mRNA elongation. The invention provides genes encoding P-TEFb subunits, including human genes, and related biological components, and also provides assay methods connected with the control of transcription elongation. Particularly useful assays are those concerning the identification of substances that inhibit viral replication at the transcription elongation stage by inhibiting the binding or functional interaction of viral proteins to P-TEFb.
Patent
P-TEFb compositions, methods and screening assays
United States Patent and Trademark Office
03/28/2006
PDM V1.0, Open Access
Abstract
Details
- Title: Subtitle
- P-TEFb compositions, methods and screening assays
- Creators
- David H Price (Inventor)
- Contributors
- University of Iowa Research Foundation (Iowa City, IA, US) (Assignee)
- Resource Type
- Patent
- Publisher
- United States Patent and Trademark Office; United States
- Patent
- US Patent 7,018,836; United States Patent and Trademark Office (United States, Alexandria) - USPTO; Published; 08/951,188; 10/15/1997
- Number of pages
- 116 pages
- Language
- English
- Date published
- 03/28/2006
- Academic Unit
- UI Research Foundation; Biochemistry and Molecular Biology
- Record Identifier
- 9983762090602771
Metrics
10 File views/ downloads
18 Record Views